These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 2422270)

  • 1. Delineation and characterization of human B cell subpopulations at various stages of activation by using a B cell-specific monoclonal antibody.
    Kikutani H; Nakamura H; Sato R; Kimura R; Yamasaki K; Hardy RR; Kishimoto T
    J Immunol; 1986 Jun; 136(11):4027-34. PubMed ID: 2422270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and function of an early activation marker restricted to human B cells.
    Kikutani H; Kimura R; Nakamura H; Sato R; Muraguchi A; Kawamura N; Hardy RR; Kishimoto T
    J Immunol; 1986 Jun; 136(11):4019-26. PubMed ID: 3084651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Size-dependent B lymphocyte subpopulations: relationship of cell volume to surface phenotype, cell cycle, proliferative response, and requirements for antibody production to TNP-Ficoll and TNP-BA.
    Thompson CB; Scher I; Schaefer ME; Lindsten T; Finkelman FD; Mond JJ
    J Immunol; 1984 Nov; 133(5):2333-42. PubMed ID: 6207226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of BSF-1 during an in vivo, T-dependent immune response.
    Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
    J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human peripheral blood B lymphocyte subpopulations: functional and phenotypic analysis of surface IgD positive and negative subsets.
    Jelinek DF; Splawski JB; Lipsky PE
    J Immunol; 1986 Jan; 136(1):83-92. PubMed ID: 3484392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgM- and IgD-bearing peripheral blood lymphocytes differentiate to IgM but not IgG or IgA immunoglobulin-secreting cells.
    Saiki O; Ralph P
    Eur J Immunol; 1982 Jun; 12(6):506-10. PubMed ID: 6981514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating properties.
    Goroff DK; Stall A; Mond JJ; Finkelman FD
    J Immunol; 1986 Apr; 136(7):2382-92. PubMed ID: 2419432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration that human B cells respond differently to interleukin 2 and B cell differentiation factor based on their stages of maturation.
    Nakagawa T; Nakagawa N; Goldstein H; Volkman DJ; Fauci AS
    J Immunol; 1986 Nov; 137(10):3175-82. PubMed ID: 2945860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
    Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
    Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody.
    Boyd AW; Anderson KC; Freedman AS; Fisher DC; Slaughenhoupt B; Schlossman SF; Nadler LM
    J Immunol; 1985 Mar; 134(3):1516-23. PubMed ID: 3871451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation.
    Weiss L; Delfraissy JF; Vazquez A; Wallon C; Galanaud P; Kazatchkine MD
    J Immunol; 1987 May; 138(9):2988-93. PubMed ID: 2952731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
    Maruyama S; Kubagawa H; Cooper MD
    J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the expression of IL 2 receptors by human T and B cells: induction by the polyclonal mitogens, phorbol myristate acetate, and anti-mu antibody.
    Suzuki T; Cooper MD
    J Immunol; 1985 May; 134(5):3111-9. PubMed ID: 2580014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface phenotype of lymphoid cells from normal mice and mice treated with monoclonal anti-IgD from birth.
    Skelly RR; Baine Y; Ahmed A; Xue B; Thorbecke GJ
    J Immunol; 1983 Jan; 130(1):15-8. PubMed ID: 6600173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyclonal activation of the murine immune system by an antibody to IgD. XI. Contribution of membrane IgD cross-linking to the generation of an in vivo polyclonal antibody response.
    Goroff DK; Holmes JM; Bazin H; Nisol F; Finkelman FD
    J Immunol; 1991 Jan; 146(1):18-25. PubMed ID: 1984444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
    Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
    J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
    Sherris D; Stohl W; Mayer L
    J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-linking of surface IgM, but not surface IgD receptors, by soluble monoclonal antibodies primes murine B cells to secrete immunoglobulin in response to lymphokines.
    Phillips C; Klaus GG
    Eur J Immunol; 1993 Feb; 23(2):574-7. PubMed ID: 8436190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40).
    Ledbetter JA; Shu G; Gallagher M; Clark EA
    J Immunol; 1987 Feb; 138(3):788-94. PubMed ID: 3492534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140.
    Pezzutto A; Dörken B; Moldenhauer G; Clark EA
    J Immunol; 1987 Jan; 138(1):98-103. PubMed ID: 3097151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.